Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 88,406 | 119,318 | 75,687 | 54,857 | 25,576 |
| Operating Income | -88,406 | -119,318 | -75,687 | -54,857 | -25,576 |
| Other Income | 116 | 2,095 | 889 | 1,679 | 1,803 |
| Pre-tax Income | -88,290 | -117,223 | -74,798 | -53,178 | -23,773 |
| Net Income Continuous | -88,290 | -117,223 | -74,798 | -53,178 | -23,773 |
| Minority Interests | N/A | N/A | N/A | -1,060 | -2,234 |
| Net Income | $-88,290 | $-117,223 | $-74,798 | $-52,118 | $-21,539 |
| EPS Basic Total Ops | -25.50 | -43.63 | -33.73 | -43.18 | -152.02 |
| EPS Basic Continuous Ops | -25.50 | -43.62 | -33.71 | -58.41 | -209.78 |
| EPS Diluted Total Ops | -25.50 | -43.63 | -33.73 | -43.18 | -152.02 |
| EPS Diluted Continuous Ops | -25.50 | -43.62 | -33.71 | -58.41 | -209.78 |
| EPS Diluted Before Non-Recurring Items | -24.89 | -43.63 | N/A | N/A | N/A |
| EBITDA(a) | $-84,504 | $-116,773 | $-74,211 | $-54,203 | $-25,015 |